Akso Health Group (AHG)
NASDAQ: AHG · IEX Real-Time Price · USD
1.27
-0.10 (-7.30%)
Aug 12, 2022 12:50 PM EDT - Market open
Ratios and Metrics (Trailing)
Market cap in millions USD. Fiscal year is April - March.
Millions USD. Fiscal year is Apr - Mar.
| Quarter Ending | Current | 2021-03-31 | 2020-03-31 | 2019-09-30 | 2019-06-30 | 2019-03-31 | 2018-12-31 | 2018-09-30 | 2018-06-30 | 2018-03-31 | 2017-12-31 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Market Capitalization
|
30 | 29 | 21 | 75 | 117 | 160 | 120 | 378 | 482 | 516 | 504 |
| Market Cap Growth
|
- | -82.12% | -82.76% | -80.08% | -75.73% | -68.97% | -76.23% | - | - | - | - |
| Enterprise Value
|
20 | 18 | 22 | 65 | 84 | 86 | 29 | 268 | 305 | 355 | 365 |
| PE Ratio
|
- | -0.82 | -0.29 | -3.10 | -3.74 | 28.95 | 6.08 | 6.73 | 5.59 | 7.88 | 9.58 |
| PS Ratio
|
17.24 | 16.32 | 2.99 | -1.79 | -2.72 | 43.35 | 1.41 | 3.00 | 3.36 | 4.81 | 5.79 |
| PB Ratio
|
1.75 | 1.66 | 0.43 | 0.75 | 1.02 | 1.27 | 1.00 | 2.95 | 2.93 | 3.69 | 4.24 |
| P/FCF Ratio
|
3.01 | 2.85 | - | - | - | - | - | - | - | 5.92 | - |
| P/OCF Ratio
|
3.01 | 2.85 | - | - | - | - | - | - | - | 5.89 | - |
| EV/Sales Ratio
|
11.19 | 21.94 | 2.44 | -1.70 | -1.85 | 30.51 | 0.79 | 1.82 | 2.43 | 3.51 | 5.17 |
| EV/EBITDA Ratio
|
- | - | - | - | - | 17.73 | - | - | - | 4.92 | - |
| EV/EBIT Ratio
|
- | - | - | - | - | 17.78 | 2.29 | 3.23 | 3.41 | 4.93 | 7.42 |
| EV/FCF Ratio
|
1.95 | 3.83 | - | - | - | - | - | - | - | 4.32 | - |
| Debt / Equity Ratio
|
0.58 | 0.58 | 0.43 | 0.24 | 0.19 | 0.16 | 0 | 0 | 0 | 0 | 0 |
| Debt / EBITDA Ratio
|
-0.31 | -0.31 | -0.30 | - | - | 3.15 | 0 | 0 | 0 | 0 | 0 |
| Debt / FCF Ratio
|
0.99 | 0.99 | -0.35 | - | - | -11.54 | 0 | 0 | 0 | 0 | 0 |
| Current Ratio
|
2.09 | 2.09 | 4.21 | 3.15 | 5.09 | 3.68 | 5.60 | 5.95 | 7.49 | 6.84 | 6.74 |
| Asset Turnover
|
0.03 | 0.03 | 0.06 | -0.28 | -0.28 | 0.02 | 0.53 | 0.78 | 1.03 | 1.12 | - |
| Return on Equity (ROE)
|
-106.50% | -106.50% | -81.60% | -21.00% | -25.60% | 4.10% | 14.30% | 40.70% | 73.50% | 80.10% | - |
| Return on Assets (ROA)
|
-62.10% | -62.10% | -56.10% | -16.50% | -20.60% | 3.40% | 12.30% | 34.60% | 61.60% | 68.10% | - |
| Return on Capital (ROIC)
|
-68.20% | -68.20% | -71.20% | -25.30% | -37.20% | 9.30% | 67.90% | 341.80% | 9692.30% | 1308.60% | - |
| Earnings Yield
|
-115.09% | -121.60% | -344.52% | -32.28% | -26.73% | 3.45% | 16.46% | 14.87% | 17.88% | 12.68% | 10.44% |
| FCF Yield
|
33.24% | 35.12% | -282.94% | - | - | -1.08% | - | - | - | 16.90% | - |
| Dividend Yield
|
- | - | - | - | 49.79% | 36.48% | 48.98% | 15.47% | - | - | - |
| Payout Ratio
|
- | 0.00% | 0.00% | 0.00% | -60.60% | 363.60% | 95.20% | 33.30% | 0.00% | 0.00% | 0.00% |
| Buyback Yield / Dilution
|
7.70% | 7.70% | 0.37% | -0.15% | 8.34% | -11.03% | 5.04% | -13.53% | -23.51% | -12.58% | - |
| Total Shareholder Return
|
7.70% | 7.70% | 0.37% | -0.15% | 58.13% | 25.45% | 54.02% | 1.94% | -23.51% | -12.58% | 0.00% |
Source: Financials are provided by
Nasdaq Data Link
and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).